| CAS: | 476159-98-5 | |
| 分子式: | C23H27ClN4O3 | |
| 分子量: | 442.94 | |
| 英文名称: |
| |
| 用途: | AZM475271是Src激酶高效选择性抑制剂,IC50值为5nM,对Flt3、KDR和Tie-2抑制剂弱(IC50>10uM)。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||
| A878919 | MACKLIN | AZM475271 | ≥99% | 1600元/10mg; | 咨询 | ||||||||||||||||||||||||||||
储存:2-8℃ | |||||||||||||||||||||||||||||||||
| SML2572 | Sigma-Aldrich | AZM475271 | ≥98% (HPLC) | 1179.67元/5 MG; 7933.92元/25 MG; | 咨询 | ||||||||||||||||||||||||||||
产品说明 生化/生理作用 AZM475271 (M475271) is an orally active, potent and selective inhibitor against src family kinases src and yes (IC50 = 25 nM & 10 nM, respectively; lck/VEGFR2/EGFR/csk/FGFR1 IC50 = 0.2/0.5/0.6/7.6/∼20 μM) that effectively suppresses src-dependent cellular signaling events (26%/48% inhibition of 50 ng/mL VEGF-induced HUVEC proliferation/migration at 100 nM; 31%/72% inhibition of 10 ng/mL VEGF-induced Flk-1/Src phosphorylation in HUVECs at 300 nM) and exbihits anticancer efficacy both in cultures (70% PC-9/30% A549 proliferation inhibition at 1 μM) and in vivo (78%/100% PC-9 tumor growth suppression in mice via 10/50 mg/kg/day p.o.). 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||